Revolution Medicines, Inc.RVMDNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +52.74% | +18.81% | +14.22% | +13.93% | +13.42% |
| Weighted Average Shares Diluted Growth | +52.74% | +18.81% | +14.22% | +13.93% | +13.42% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | -100.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +79.12% | +24.09% | +23.95% | +34.35% | +27.73% |
| Book Value per Share Growth | +22.45% | +4.40% | +5.45% | +1.14% | -10.11% |
| Debt Growth | +37.96% | +54.47% | +52.61% | +51.91% | +82.76% |
| R&D Expense Growth | +40.86% | +26.68% | +74.33% | +66.11% | +72.98% |
| SG&A Expenses Growth | +54.45% | -12.50% | +53.30% | +86.91% | +120.21% |